Immune inactivation by APOBEC3B enrichment predicts response to chemotherapy and survival in gastric cancer-Reference-Cited by-同舟云学术

Immune inactivation by APOBEC3B enrichment predicts response to chemotherapy and survival in gastric cancer

Published:2021-01-01 Issue:1 Volume:10 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Xia Siyu¹,Gu Yun²,Zhang Haijian³,Fei Yuchao²,Cao Yifan⁴,Fang Hanji²,Wang Jieti⁵,Lin Chao⁴,Zhang Heng⁴,Li He⁴,He Hongyong⁴,Xu Jiejie²^ORCID,Li Ruochen⁴^ORCID,Liu Hao⁴,Zhang Weijuan¹^ORCID

Affiliation:

1. Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China

2. Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China

3. Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, China

4. Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

5. Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, China

Funder

National Natural Science Foundation of China

Shanghai Sailing Program

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2021.1975386

Reference47 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Viruses and Human Cancers: a Long Road of Discovery of Molecular Paradigms

3. Oncogenic viruses and cancer

4. Going viral? Linking the etiology of human prostate cancer to the PCA 3 long noncoding RNA and oncogenic viruses

5. Immune Responses to Retroviruses

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. APOBEC family reshapes the immune microenvironment and therapy sensitivity in clear cell renal cell carcinoma;Clinical and Experimental Medicine;2024-09-09

2. Regulation, functional impact, and therapeutic targeting of APOBEC3A in cancer;DNA Repair;2024-09

3. HLA polymorphism impacts immune response to neoepitopes and survival in APOBEC-mutated cancers;2024-08-08

4. Exploration of molecular markers related to chemotherapy efficacy of hepatoid adenocarcinoma of the stomach;Cellular Oncology;2023-11-09

5. MiR-138–5p inhibits prostate cancer cell proliferation and chemoresistance by targeting APOBEC3B;Translational Oncology;2023-09